Figure 8
Chaperoning the NK-cell–deficient phase of haplo-identical HSC transplantation. Delineation of a hypothetical study design in relapsing pediatric BCP-ALL patients ideally exploiting NK-cell–mediated antitumor responses.
Chaperoning the NK-cell–deficient phase of haplo-identical HSC transplantation. Delineation of a hypothetical study design in relapsing pediatric BCP-ALL patients ideally exploiting NK-cell–mediated antitumor responses.
